Gangjihwan Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed C57BL/6N Mice

고지방식이 C57BL/6N 모델에서 강지환(降脂丸)의 농도별 비알콜성 지방간질환 개선효과

  • Received : 2014.02.12
  • Accepted : 2014.03.12
  • Published : 2014.03.30


Objectives : This study was undertaken to verify the effect of Gangjihwan(Di-fatty, DF) composed with Pakistani Ephedra Herba on nonalcoholic fatty liver disease(NAFLD) using high fat diet-fed male mice. Method : Eight-week old C57BL/6N mice were used for all experiments. Standard chow diet-fed mice were used as normal group and high fat diet-fed NAFLD mice were randomly divided into 5 groups: control, atorvastatin, DF(1), DF(2) and DF(3). After 8 weeks, mice were treated with water, atorvastatin(10mg/kg) and DF(40, 80, 160mg/kg) for 8 weeks. And we investigated body weight gain, plasma lipid and glucose metabolism, histological analysis for liver on the mice. Results : Compared with controls, DF-treated mice had very significantly lower body weight gain and lower visceral adipose tissue weight, the magnitudes of which were prominent in DF(3). Consistent with their effects on body weight gain, DF-treated mice had lower blood total cholesterol and triglyceride level compared with controls. Consistent with their effects on body weight gain and blood plasma lipid level, DF-treated mice had lower liver weight and hepatic lipid accumulation of DF-treated groups was significantly decreased than control group. Also Blood plasma AST, ALT and ${\gamma}$-GT concentration were not changed by DF, and these results may indicate DF do not show any toxic effects. Conclusions : These results suggest that DF effectively improves NAFLD. DF reduces liver weight and prevents lipid accumulation of hepatocyte by reducing body weight gain and modulating blood plasma lipid metabolism levels.


Gangjihwan;DF;Di-fatty;nonalcoholic fatty liver disease;NAFLD;triglyceride;cholesterol


  1. Reynoso E, Lavine JE. NAFLD: The role of exercise in treating NAFLD. Nat Rev Gastroenterol Hepatol. 2012 ; 9 : 368-70.
  2. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005 ; 42(1) : 132-8.
  3. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001 ; 50 : 1844-50.
  4. MGaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013 ; 5 : 1544-60.
  5. Shen YJ. Pharmacology of traditional Chinese Medicine. First edition. Beijing : People's Medical Publishing House. 2000 : 111-5.
  6. Wang YS, Deng WL, Xue CS. The application and pharmacology of traditional Chinese Medicine. Second edition. Beijing : People's Medical Publishing House. 2000 : 1105-19.
  7. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003 ; 289(12) : 1537-45.
  8. Vukovich MD, Schoorman R, Heilman C, Jacob P 3rd, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clin Exp Pharmacol Physiol. 2005; : 32(1-2) : 47-53.
  9. Tian JY, Chen L, Zhang XL, Li J, Han J, Fu JY, Yang XM, Zhang PC, Ye F. Investigation of a compound, compatibility of Rhodiola crenulata, Cordyceps militaris, and Rheum palmatum, on metabolic syndrome treatment II - improving obesity. Zhongguo Zhong Yao Za Zhi. 2013 ; 38(9) : 1411-5.
  10. Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev. 2010 ; 11 : 430-45.
  11. Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 2000 ; 26 : 98-106.
  12. Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2009 ; 19 : 291-302.
  13. Kim TK, Jung WS, Park SW, Cho KH, Kim YS. Comparison of efficacy and safety between Chunghyul-dan(HH-333) and Atorvastatin(Lipitor$^{(R)}$). Kor J Orient Int Med. 2003 ; 24(4) : 837-45.
  14. Korea Food & Drug Administration. The press release. Retrieved Nov. 14, 2013, from
  15. Durazzo M, Belci P, Collo A, Grisoglio E, Bo S. Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease. Int J Hepatol. 2012 ; 2012 : 464706.
  16. Professors of herbology in college of oriental medicine. Herbology. Seoul : Younglimsa. 2006 : 154-6, 240-1.
  17. Hwang MJ, Shin HD, Song MY. Literature Review of Herbal Medicines on Treatment of Obesity Since 2000 - Mainly about Ephedra Herba. J Kor Med Obes Res. 2007 ; 7(1) : 39-54.
  18. Joh HG, Yang JM, Kim DI. Effects of the oral administration of Epedra Sinica Extract on suppression of body weight gains and the DNA chip expression of obese rats. J Kor Med Obstet Gynecol. 2007 ; 20(3) : 65-80.
  19. Cheon MS, Yoon TS, Choi GC, Kim SJ, Lee AY, Moon BC, Choo BK, Kim HK. Comparative Study of Extracts from Rhubarb on Inflammatory Activity in Raw 264.7 Cells. Kor J Med Crop Sci. 2009 ; 17(2) : 109-14.
  20. Jang TY, Nam SK, Kim HG, Kim HY, Lee JS, Jung HA, Ko YC, Shin SH. Effects of Radix et Rhizoma Rhei on the Renal Function and Vessel in the Diabetic Rats. Kor J Orient Intern Med. 2006 ; 27(4) : 845-54.
  21. Son YJ, Kim YS, Lee YJ. The Effects of Rhei palmati Radix and Rhei undulati Radix on the Blood Lipids and Enzymes of Hypercholesterolic Rats. Kor J Herbology. 1999 ; 14(1) : 61-8.
  22. Lee YJ. The Effects of Fraction Obtained from Rhei Rhizoma on the Blood Lipids in Hypercholesterol Rats. Kor J Herbology. 2000 ; 15(2) : 87-93.
  23. Kim HH, Park SY, Ahn DK, Park SK. Vasodilation Effects between the Water Extract of Rheum palmatum L. and R. undulatum L. in Rat Thoracic Aorta. Kor J Herbology. 2004 ; 19(3) : 99-105.
  24. Ryu HS, Kim SP, Kim SM, Lee DG, Lee OJ, Lee JH, Wei TS. The effects of Rhei Radix et Rhizoma Pharmacopuncture at Bi-Su($BL_{20}$) on the Obese Rats Induced by High Fat Diet. The Acupuncture. 2012 ; 29(3) : 9-18.
  25. Ju JH, Cho HH, Lee YS. Progress on Phytochemical and Atopic Dermatitis-related Study of the Root of Lithospermum erythrorhizon. Kor J Pharmacogn. 2010 ; 41(2) : 73-88.
  26. Choi SB, Bae GS, Jo IJ, Park KC, Seo SH, Kim DG, Shin JY, Gwak TS, Lee JH, Lee GS, Park SJ, Song HJ. The anti-inflammatory effect of Lithospermum Erythrorhizon on lipopolysaccharide - induced inflammatory response in RAW 264.7 cells. Kor J Herbology. 2013 ; 28(2) : 67-73.
  27. Kwon MH, Lee JY, Kim DG. Anti-allergic and Anti-inflammatory Effects of Jacho(Lithospermum Erythrorhizon). J Kor med. 2005 ; 26(3) : 110-23.
  28. Molleston JP, Schwimmer JB, Yates KP, Murray KF, Cummings OW, Lavine JE, Brunt EM, Scheimann AO, Unalp-Arida A. Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels. J Pediatr(in press).

Cited by

  1. Comparison of Gangjihwan-1,2,3,4 and Combination of Gangjihwan-1 and Gamisochehwan in the Improvement Effects of Nonalcoholic Fatty Liver Disease in a High Fat Diet-Fed Obese Mouse Model vol.29, pp.6, 2014,


Supported by : 한국연구재단